Abstract 6326: Dose-Response Efficacy and Safety of the Aldosterone Synthase Inhibitor Baxdrostat in Resistant Hypertension: A Systematic Review and Network Meta-Analysis
Background: Resistant hypertension (RH) is associated with increased cardiovascular morbidity and mortality, with limited treatment options due to adverse effects and suboptimal control. Aldosterone plays a central role in RH pathophysiology, making aldosterone synthase inhibition a promising therapeutic target. Bax...